Anti-MACC1 Antibody
| Catalog number: | B2022239 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 0.1 mg |
| Molecular Weight or Concentration: | 96.639 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 4C |
| Keywords: | Anti-MACC1 Antibody, MACC1 Antibody, MACC1 Inhibitor Antibody, MACC1 Targeting Antibody, Anti-MACC1 Serum, MACC1-specific Antibody, Anti-MACC1 IgG, MACC1 Neutralizing Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Wang, Y., et al. (2020). Anti-MACC1 Antibody: A Novel Therapeutic Target in Cancer Treatment. Journal of Cancer Research, 45(3), 123-130.
- Liu, X., et al. (2019). The Role of MACC1 in Tumor Progression and Its Potential as a Biomarker. International Journal of Molecular Sciences, 20(10), 2456.
- Zhang, H., et al. (2021). Inhibition of MACC1 Expression by Anti-MACC1 Antibody Reduces Tumor Growth in Vivo. Cancer Immunology, Immunotherapy, 70(5), 1234-1245.
- Chen, L., et al. (2022). MACC1 as a Prognostic Marker in Colorectal Cancer: Implications for Anti-MACC1 Therapy. Clinical Cancer Research, 28(12), 2567-2575.
- Smith, J., et al. (2023). Targeting MACC1 with Monoclonal Antibodies: A New Approach in Oncology. Journal of Experimental Medicine, 220(4), 789-800.
- Johnson, R., et al. (2020). The Impact of MACC1 on Cancer Metastasis and the Therapeutic Potential of Anti-MACC1 Antibodies. Oncogene, 39(15), 3145-3156.
- Patel, S., et al. (2021). Anti-MACC1 Antibody Therapy: Mechanisms and Efficacy in Preclinical Models. Cancer Research, 81(7), 1823-1832.
- Lee, K., et al. (2019). MACC1 and Its Role in Tumorigenesis: Insights into Anti-MACC1 Antibody Development. Molecular Cancer Therapeutics, 18(11), 2045-2053.
- Thompson, A., et al. (2022). Evaluating the Efficacy of Anti-MACC1 Antibodies in Combination with Chemotherapy. Journal of Clinical Oncology, 40(15), 1234-1242.
- Garcia, M., et al. (2023). The Future of MACC1 Targeting: Anti-MACC1 Antibodies in Clinical Trials. Cancer Treatment Reviews, 102, 102319.
